Worth Venture Partners’s LifeMD LFMD Stock Holding History

Worth Venture Partners’s Portfolio LFMD Stock Details LFMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-10,269	Closed	-$64.2K	–	154
2023 Q3	$64.2K	Buy	+10,269	New	+$44.5K	0.04%	126

Other funds holding LFMD

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GIPM

G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return

EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Worth Venture Partners's LFMD Position: Q4 2023 in Review

Worth Venture Partners sold out of LifeMD (LFMD) in Q4 2023, closing a stake of 10,269 shares — an estimated $64.2K sold.

Worth Venture Partners first reported a position in LFMD in Q3 2023 and held it in 1 quarter. The position peaked at $64.2K in Q3 2023. 84 funds tracked by Wall St. Rank hold LFMD as of Q4 2023.

Worth Venture Partners reported no remaining LifeMD position as of Q4 2023 after selling out during the quarter.
Worth Venture Partners sold 10,269 LifeMD shares in Q4 2023, an estimated $64.2K.
Worth Venture Partners first reported a position in LifeMD in Q3 2023 and held it in 1 quarter.
Worth Venture Partners's LifeMD position peaked at $64.2K in Q3 2023.
84 funds tracked by Wall St. Rank held LifeMD as of Q4 2023.

Based on Worth Venture Partners's 13F filing for Q4 2023, filed 9 Feb 2024.